Cellter

Let’s reinvent the medicine we need Why are we here? Leading causes of death in the world Cardiovascular Diseases (CVDs) and Cancer are the leading causes of death and morbidity in the world, being considered as the major barriers to sustainable human development. WHO estimates that the number of new cases for each one of these diseases will increase by up to 70% in the next 20 years due to aging population. Currently Drug Discovery and Development process are time-consuming, expensive, with a high rate of failure and once drugs reach the market some still may fail due to the differences in populations. This rise far more concern in Latam developing countries which is the faster-aging region in the world and which accounts for only 5% of the populations studied in Drug development processes. What would happen if we speed up the search for life-saving drugs taking account the population differences and the major drawbacks since the beginning?. Well the chances boost up. This is why Cellter is born. This is why we’re here. All action is an opportunity. To learn. To change… Get better We’re a biotech startup combining AI-powered big data and drug design solutions to speed Up the search for diagnostics, medicines and therapies. We are solving the equation between time, costs, risk and efficiency. Creating revolutionary nano drugs to treat high incidence diseases and finding new therapies for unmet medical needs that will deliver life-changing innovations for all.

,
Founded in 2016
1-10 employees

Let’s reinvent the medicine we need Why are we here? Leading causes of death in the world Cardiovascular Diseases (CVDs) and Cancer are the leading causes of death and morbidity in the world, being considered as the major barriers to sustainable human development. WHO estimates that the number of new cases for each one of these diseases will increase by up to 70% in the next 20 years due to aging population. Currently Drug Discovery and Development process are time-consuming, expensive, with a high rate of failure and once drugs reach the market some still may fail due to the differences in populations. This rise far more concern in Latam developing countries which is the faster-aging region in the world and which accounts for only 5% of the populations studied in Drug development processes. What would happen if we speed up the search for life-saving drugs taking account the population differences and the major drawbacks since the beginning?. Well the chances boost up. This is why Cellter is born. This is why we’re here. All action is an opportunity. To learn. To change… Get better We’re a biotech startup combining AI-powered big data and drug design solutions to speed Up the search for diagnostics, medicines and therapies. We are solving the equation between time, costs, risk and efficiency. Creating revolutionary nano drugs to treat high incidence diseases and finding new therapies for unmet medical needs that will deliver life-changing innovations for all.

Company Information

Industry
Company Type
Privately Held
Founded
2016
Employee Range
1-10
Revenue Range
Not available

Location

Address
San Ignacio 1372, Office 102 Santiago
City
Region
Postal Code
Country
Chile

Web Presence

Ready to automate your outreach?

Get unlimited access to our company database — complete with detailed profiles, funding info, and tech stacks — and start sending personalized emails with AI-powered follow-ups.

Frequently Asked Questions